Please login to the form below

Not currently logged in
Email:
Password:

Lucid picks up rare disease and orphan drugs trophy at PMEA 2017

Judges praised the AbbVie project for its impressive reach

Winners

Lucid picked up the award for Excellence in Rare Diseases and Orphan Drugs at this year’s PMEA Awards, which were hosted in London earlier this week.

The agency’s ‘EIDON’ project for AbbVie developed a specialist network and increased the number of specialist centres to advance outcomes of patients with hidradenitis suppurativa (HS).

AbbVie employees, with support from Lucid Group, developed small-group, in clinical training sessions and out of the 62 delegates, 26 of them are establishing new centres, advancing the quality of care in 7,300 patients per year.

PMEA’s judges said: “The Eidon project took a whole programme approach, building awareness from zero to create a network and care delivery infrastructure.

“It is a clearly-structured entry with key behaviours and outcomes defined and measured, and most important, an impressive number of patients were treated.”

Narrowly missing first place, but still achieving a highly commended status on the night was Amicus Therapeutics UK for its work on rare diseases.

Judges said: “Amicus did a very good job for a small outfit in the start-up phase and they showed an extraordinary understanding of payers.”

Run by PMLiVE’s publisher the PMGroup, PMEA exists to reward responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes.

The programme has been specifically designed to recognise and commend excellence, best practice and innovation in local, European and international markets.

* See all the results from PMEA 2017

* View the PMEA 2017 photo gallery

Article by
Gemma Jones

16th November 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...